论文部分内容阅读
引言:“这是一条艰苦又漫长的道路,因为没有到最后一刻,你根本看不到成功”。这就是吴丽玉谈起当初不顾一切,将所有资金投入研究生物科技的心情。的确,医药业是高技术、高风险、高投入的产业。没有雄厚的资金、高新技术与人才做支撑是根本无法进行下去的。现代生物技术的飞速发展,对医药工业产生革命性影响,对疑难疾病认识的深化,众多新型生物技术药物的问世,用生物技术改造传统产业等都将极大地改变医药工业的面貌。国鼎生物科技公司在总裁吴丽玉的领导下,经过八年的漫长岁月,国鼎生物科技公司研发出癌症新药——安卓奎诺尔,为医药事业做出了应有贡献。
Introduction: “This is a difficult and long way, because you do not see success until the last minute.” This is Wu Liyu talked about the original desperation, all funds into research biotechnology mood. Indeed, the pharmaceutical industry is a high-tech, high-risk, high-input industry. Without abundant capital, high-tech and talent support is simply impossible to go on. The rapid development of modern biotechnology, the revolutionary impact on the pharmaceutical industry, the deepening understanding of difficult diseases, the advent of many new biotech drugs, and the use of biotechnology to transform traditional industries will greatly change the face of the pharmaceutical industry. Under the leadership of president Wu Liyu, Guoding Biotech Co., Ltd. has made its contribution to the cause of medicine after a long time of eight years.